5VM
5AM Venture Management Portfolio holdings
AUM
$260M
This Quarter Return
+12.56%
1 Year Return
+3.76%
3 Year Return
+144.87%
5 Year Return
+32.61%
10 Year Return
–
AUM
$401M
AUM Growth
+$401M
(+2.7%)
Cap. Flow
+$15.2M
Cap. Flow
% of AUM
3.78%
Top 10 Holdings %
Top 10 Hldgs %
79.05%
Holding
28
New
4
Increased
3
Reduced
1
Closed
4
Top Buys
| 1 |
MoonLake Immunotherapeutics
MLTX
|
$16.3M |
| 2 |
Zentalis Pharmaceuticals
ZNTL
|
$13.8M |
| 3 |
Celldex Therapeutics
CLDX
|
$10.5M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$6.96M |
| 5 |
Viking Therapeutics
VKTX
|
$3.81M |
Top Sells
| 1 |
IDEAYA Biosciences
IDYA
|
$11.9M |
| 2 |
FibroGen
FGEN
|
$10.8M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$6.92M |
| 4 |
Disc Medicine
IRON
|
$4.44M |
| 5 |
PEAR
Pear Therapeutics, Inc. Class A Common Stock
PEAR
|
$4.27M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
IDEAYA Biosciences
IDYA
$2.16B
| – | – |
-868,520
| Closed | -$11.9M |
|
|
ISEE
27
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| – | – |
-284,626
| Closed | -$6.92M |
|
|
PEAR
28
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
| – | – |
-16,744,113
| Closed | -$4.27M |
|